Its growth is attributed to the rising incidence of neurological disorders. The implantable neurostimulation devices market ...

Burns et al. used a self-contained miniature implantable neurostimulator, called a bion, to deliver ONS to six patients with hemicrania continua, a rare unilateral form of primary headache.

While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now ...

The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

The neuromodulation developer Saluda Medical announced that it raised $100 million to help bolster the sales of its ...

Onward Medical today announced the first commercial sales of its ARC-EX spinal cord stimulation system (SCS) in the U.S.

The neurostimulator, which sends electrical signals ... which is particularly useful in children because the implant is in the skull and not in the chest. "We hope this will reduce the potential ...

Mainstay Medical Holdings announces outcomes from RESTORE clinical trial of ReActiv8 to treat intractable chronic low back pain: Dublin, Ireland Saturday, January 18, 2025, 18:00 ...

Conclusions: When implanted contemporarily with sacral or spinal neurostimulators, cardiac devices appear to be safe, as confirmed by the appropriate detection and interruption of arrhythmic episodes.